Comment on “Response to direct-acting antiviral agents in chronic hepatitis C patients with end-stage renal disease: a clinical experience”
Year: 2021
Type: editorial
Abstract: We read with great interest the study by Tatar et al. 1 in which they demonstrated that treatment with OBV/PTV/r and DSV with or without RBV resulted in high rates of sustained virologic response in HCV GT1-infected patients with end-stage renal disease. Although this article is interesting, in our opinion, some issues should be addressed.
Authors: Xiaofei Li, Lianqing Lou
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W3208917573